Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

The Role of Metabotropic Glutamate Receptor 1 Dependent Signaling in Glioma Viability.

Dalley CB, Wroblewska B, Wolfe BB, Wroblewski JT.

J Pharmacol Exp Ther. 2018 Oct;367(1):59-70. doi: 10.1124/jpet.118.250159. Epub 2018 Jul 27.

PMID:
30054311
2.

The (α4)3(β2)2 Stoichiometry of the Nicotinic Acetylcholine Receptor Predominates in the Rat Motor Cortex.

DeDominicis KE, Sahibzada N, Olson TT, Xiao Y, Wolfe BB, Kellar KJ, Yasuda RP.

Mol Pharmacol. 2017 Sep;92(3):327-337. doi: 10.1124/mol.116.106880. Epub 2017 Jul 11.

3.

Hydrologic monitoring tools for freshwater municipal planning in the Arctic: the case of Iqaluit, Nunavut, Canada.

Bakaic M, Medeiros AS, Peters JF, Wolfe BB.

Environ Sci Pollut Res Int. 2018 Nov;25(33):32913-32925. doi: 10.1007/s11356-017-9343-4. Epub 2017 Jun 6.

PMID:
28589278
4.

Distribution and diversity of diatom assemblages in surficial sediments of shallow lakes in Wapusk National Park (Manitoba, Canada) region of the Hudson Bay Lowlands.

Jacques O, Bouchard F, MacDonald LA, Hall RI, Wolfe BB, Pienitz R.

Ecol Evol. 2016 Jun 9;6(13):4526-40. doi: 10.1002/ece3.2179. eCollection 2016 Jul.

5.

Spatiotemporal patterns of mercury accumulation in lake sediments of western North America.

Drevnick PE, Cooke CA, Barraza D, Blais JM, Coale KH, Cumming BF, Curtis CJ, Das B, Donahue WF, Eagles-Smith CA, Engstrom DR, Fitzgerald WF, Furl CV, Gray JE, Hall RI, Jackson TA, Laird KR, Lockhart WL, Macdonald RW, Mast MA, Mathieu C, Muir DCG, Outridge PM, Reinemann SA, Rothenberg SE, Ruiz-Fernández AC, Louis VLS, Sanders RD, Sanei H, Skierszkan EK, Van Metre PC, Veverica TJ, Wiklund JA, Wolfe BB.

Sci Total Environ. 2016 Oct 15;568:1157-1170. doi: 10.1016/j.scitotenv.2016.03.167. Epub 2016 Apr 18.

PMID:
27102272
6.
7.

Paleolimnological assessment of riverine and atmospheric pathways and sources of metal deposition at a floodplain lake (Slave River Delta, Northwest Territories, Canada).

MacDonald LA, Wiklund JA, Elmes MC, Wolfe BB, Hall RI.

Sci Total Environ. 2016 Feb 15;544:811-23. doi: 10.1016/j.scitotenv.2015.11.173. Epub 2015 Dec 11.

8.

Atypical signaling of metabotropic glutamate receptor 1 in human melanoma cells.

Gelb T, Pshenichkin S, Hathaway HA, Grajkowska E, Dalley CB, Wolfe BB, Wroblewski JT.

Biochem Pharmacol. 2015 Nov 1;98(1):182-9. doi: 10.1016/j.bcp.2015.08.091. Epub 2015 Aug 17.

PMID:
26291396
9.

AT-1001 Is a Partial Agonist with High Affinity and Selectivity at Human and Rat α3β4 Nicotinic Cholinergic Receptors.

Tuan EW, Horti AG, Olson TT, Gao Y, Stockmeier CA, Al-Muhtasib N, Bowman Dalley C, Lewin AE, Wolfe BB, Sahibzada N, Xiao Y, Kellar KJ.

Mol Pharmacol. 2015 Oct;88(4):640-9. doi: 10.1124/mol.115.099978. Epub 2015 Jul 10.

10.

Source Apportionment of Background PAHs in the Peace-Athabasca Delta (Alberta, Canada) Using Molecular Level Radiocarbon Analysis.

Jautzy JJ, Ahad JM, Hall RI, Wiklund JA, Wolfe BB, Gobeil C, Savard MM.

Environ Sci Technol. 2015 Aug 4;49(15):9056-63. doi: 10.1021/acs.est.5b01490. Epub 2015 Jul 9.

PMID:
26115178
11.

Chloride is an Agonist of Group II and III Metabotropic Glutamate Receptors.

DiRaddo JO, Miller EJ, Bowman-Dalley C, Wroblewska B, Javidnia M, Grajkowska E, Wolfe BB, Liotta DC, Wroblewski JT.

Mol Pharmacol. 2015 Sep;88(3):450-9. doi: 10.1124/mol.114.096420. Epub 2015 Jun 18.

PMID:
26089372
12.

Science-policy processes for transboundary water governance.

Armitage D, de Loë RC, Morris M, Edwards TW, Gerlak AK, Hall RI, Huitema D, Ison R, Livingstone D, MacDonald G, Mirumachi N, Plummer R, Wolfe BB.

Ambio. 2015 Sep;44(5):353-66. doi: 10.1007/s13280-015-0644-x. Epub 2015 Mar 14.

13.

Limnological regime shifts caused by climate warming and Lesser Snow Goose population expansion in the western Hudson Bay Lowlands (Manitoba, Canada).

MacDonald LA, Farquharson N, Merritt G, Fooks S, Medeiros AS, Hall RI, Wolfe BB, Macrae ML, Sweetman JN.

Ecol Evol. 2015 Feb;5(4):921-39. doi: 10.1002/ece3.1354. Epub 2015 Jan 30.

14.

Pharmacological characterization of mGlu1 receptors in cerebellar granule cells reveals biased agonism.

Hathaway HA, Pshenichkin S, Grajkowska E, Gelb T, Emery AC, Wolfe BB, Wroblewski JT.

Neuropharmacology. 2015 Jun;93:199-208. doi: 10.1016/j.neuropharm.2015.02.007. Epub 2015 Feb 17.

15.

Metabotropic glutamate receptor 1 acts as a dependence receptor creating a requirement for glutamate to sustain the viability and growth of human melanomas.

Gelb T, Pshenichkin S, Rodriguez OC, Hathaway HA, Grajkowska E, DiRaddo JO, Wroblewska B, Yasuda RP, Albanese C, Wolfe BB, Wroblewski JT.

Oncogene. 2015 May 21;34(21):2711-20. doi: 10.1038/onc.2014.231. Epub 2014 Jul 28.

16.

From student to steward: the Interdisciplinary Program in Neuroscience at Georgetown University as a case study in professional development during doctoral training.

Ullrich L, Dumanis SB, Evans TM, Jeannotte AM, Leonard C, Rozzi SJ, Taylor CM, Gale K, Kanwal JS, Maguire-Zeiss KA, Wolfe BB, Forcelli PA.

Med Educ Online. 2014 Jul 7;19:22623. doi: 10.3402/meo.v19.22623. eCollection 2014.

17.

A real-time method for measuring cAMP production modulated by Gαi/o-coupled metabotropic glutamate receptors.

DiRaddo JO, Miller EJ, Hathaway HA, Grajkowska E, Wroblewska B, Wolfe BB, Liotta DC, Wroblewski JT.

J Pharmacol Exp Ther. 2014 Jun;349(3):373-82. doi: 10.1124/jpet.113.211532. Epub 2014 Mar 21.

PMID:
24659805
18.

Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain.

Hussmann GP, DeDominicis KE, Turner JR, Yasuda RP, Klehm J, Forcelli PA, Xiao Y, Richardson JR, Sahibzada N, Wolfe BB, Lindstrom J, Blendy JA, Kellar KJ.

J Neurochem. 2014 May;129(4):721-31. doi: 10.1111/jnc.12653. Epub 2014 Feb 7.

19.

Has Alberta oil sands development altered delivery of polycyclic aromatic compounds to the Peace-Athabasca Delta?

Hall RI, Wolfe BB, Wiklund JA, Edwards TW, Farwell AJ, Dixon DG.

PLoS One. 2012;7(9):e46089. doi: 10.1371/journal.pone.0046089. Epub 2012 Sep 26.

20.

Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain.

Hussmann GP, Turner JR, Lomazzo E, Venkatesh R, Cousins V, Xiao Y, Yasuda RP, Wolfe BB, Perry DC, Rezvani AH, Levin ED, Blendy JA, Kellar KJ.

J Pharmacol Exp Ther. 2012 Nov;343(2):441-50. doi: 10.1124/jpet.112.198085. Epub 2012 Aug 16.

21.

Has Alberta oil sands development increased far-field delivery of airborne contaminants to the Peace-Athabasca Delta?

Wiklund JA, Hall RI, Wolfe BB, Edwards TW, Farwell AJ, Dixon DG.

Sci Total Environ. 2012 Sep 1;433:379-82. doi: 10.1016/j.scitotenv.2012.06.074. Epub 2012 Jul 20.

22.

Ligand bias at metabotropic glutamate 1a receptors: molecular determinants that distinguish β-arrestin-mediated from G protein-mediated signaling.

Emery AC, DiRaddo JO, Miller E, Hathaway HA, Pshenichkin S, Takoudjou GR, Grajkowska E, Yasuda RP, Wolfe BB, Wroblewski JT.

Mol Pharmacol. 2012 Aug;82(2):291-301. doi: 10.1124/mol.112.078444. Epub 2012 May 14.

23.

Endogenously expressed muscarinic receptors in HEK293 cells augment up-regulation of stably expressed α4β2 nicotinic receptors.

Hussmann GP, Yasuda RP, Xiao Y, Wolfe BB, Kellar KJ.

J Biol Chem. 2011 Nov 18;286(46):39726-37. doi: 10.1074/jbc.M111.289546. Epub 2011 Sep 22.

24.

Effects of chronic nicotine on heteromeric neuronal nicotinic receptors in rat primary cultured neurons.

Lomazzo E, Hussmann GP, Wolfe BB, Yasuda RP, Perry DC, Kellar KJ.

J Neurochem. 2011 Oct;119(1):153-64. doi: 10.1111/j.1471-4159.2011.07408.x. Epub 2011 Sep 1.

25.

Quantitative analysis of the heteromeric neuronal nicotinic receptors in the rat hippocampus.

Lomazzo E, MacArthur L, Yasuda RP, Wolfe BB, Kellar KJ.

J Neurochem. 2010 Nov;115(3):625-34. doi: 10.1111/j.1471-4159.2010.06967.x. Epub 2010 Sep 27.

26.

The protective signaling of metabotropic glutamate receptor 1 Is mediated by sustained, beta-arrestin-1-dependent ERK phosphorylation.

Emery AC, Pshenichkin S, Takoudjou GR, Grajkowska E, Wolfe BB, Wroblewski JT.

J Biol Chem. 2010 Aug 20;285(34):26041-8. doi: 10.1074/jbc.M110.139899. Epub 2010 Jun 21.

27.

The alpha4beta2alpha5 nicotinic cholinergic receptor in rat brain is resistant to up-regulation by nicotine in vivo.

Mao D, Perry DC, Yasuda RP, Wolfe BB, Kellar KJ.

J Neurochem. 2008 Jan;104(2):446-56. Epub 2007 Oct 24.

28.

Deletion of the GABA(A) receptor alpha1 subunit increases tonic GABA(A) receptor current: a role for GABA uptake transporters.

Ortinski PI, Turner JR, Barberis A, Motamedi G, Yasuda RP, Wolfe BB, Kellar KJ, Vicini S.

J Neurosci. 2006 Sep 6;26(36):9323-31.

29.

NMDA receptor subtypes at autaptic synapses of cerebellar granule neurons.

Lu C, Fu Z, Karavanov I, Yasuda RP, Wolfe BB, Buonanno A, Vicini S.

J Neurophysiol. 2006 Nov;96(5):2282-94. Epub 2006 Aug 2.

30.

Heterogeneity of nicotinic cholinergic receptors in rat superior cervical and nodose Ganglia.

Mao D, Yasuda RP, Fan H, Wolfe BB, Kellar KJ.

Mol Pharmacol. 2006 Nov;70(5):1693-9. Epub 2006 Aug 1.

PMID:
16882879
31.

Nicotinic cholinergic receptors in the rat retina: simple and mixed heteromeric subtypes.

Marritt AM, Cox BC, Yasuda RP, McIntosh JM, Xiao Y, Wolfe BB, Kellar KJ.

Mol Pharmacol. 2005 Dec;68(6):1656-68. Epub 2005 Aug 29.

PMID:
16129735
32.

Rapid functional recovery after spinal cord injury in young rats.

Brown KM, Wolfe BB, Wrathall JR.

J Neurotrauma. 2005 May;22(5):559-74.

PMID:
15892601
33.

Glutamate receptor subunit expression after spinal cord injury in young rats.

Brown KM, Wrathall JR, Yasuda RP, Wolfe BB.

Brain Res Dev Brain Res. 2004 Aug 18;152(1):61-8.

PMID:
15283995
34.

The nicotinic receptor in the rat pineal gland is an alpha3beta4 subtype.

Hernandez SC, Vicini S, Xiao Y, Dávila-García MI, Yasuda RP, Wolfe BB, Kellar KJ.

Mol Pharmacol. 2004 Oct;66(4):978-87. Epub 2004 Jul 9.

PMID:
15247319
35.

Differential preservation of AMPA receptor subunits in the hippocampi of Alzheimer's disease patients according to Braak stage.

Carter TL, Rissman RA, Mishizen-Eberz AJ, Wolfe BB, Hamilton RL, Gandy S, Armstrong DM.

Exp Neurol. 2004 Jun;187(2):299-309.

PMID:
15144856
36.

Biochemical and molecular studies of NMDA receptor subunits NR1/2A/2B in hippocampal subregions throughout progression of Alzheimer's disease pathology.

Mishizen-Eberz AJ, Rissman RA, Carter TL, Ikonomovic MD, Wolfe BB, Armstrong DM.

Neurobiol Dis. 2004 Feb;15(1):80-92.

PMID:
14751773
37.

Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington's mouse model.

Jarabek BR, Yasuda RP, Wolfe BB.

Brain. 2004 Mar;127(Pt 3):505-16. Epub 2003 Dec 8.

PMID:
14662521
38.

Biochemical analysis of GABA(A) receptor subunits alpha 1, alpha 5, beta 1, beta 2 in the hippocampus of patients with Alzheimer's disease neuropathology.

Rissman RA, Mishizen-Eberz AJ, Carter TL, Wolfe BB, De Blas AL, Miralles CP, Ikonomovic MD, Armstrong DM.

Neuroscience. 2003;120(3):695-704.

PMID:
12895510
39.

Association of NR3A with the N-methyl-D-aspartate receptor NR1 and NR2 subunits.

Al-Hallaq RA, Jarabek BR, Fu Z, Vicini S, Wolfe BB, Yasuda RP.

Mol Pharmacol. 2002 Nov;62(5):1119-27.

PMID:
12391275
40.

Quantitative measurement of glutamate receptor subunit protein expression in the postnatal rat spinal cord.

Brown KM, Wrathall JR, Yasuda RP, Wolfe BB.

Brain Res Dev Brain Res. 2002 Aug 30;137(2):127-33.

PMID:
12220704
41.
42.
43.
44.

Hippocampal dependent learning ability correlates with N-methyl-D-aspartate (NMDA) receptor levels in CA3 neurons of young and aged rats.

Adams MM, Smith TD, Moga D, Gallagher M, Wang Y, Wolfe BB, Rapp PR, Morrison JH.

J Comp Neurol. 2001 Apr 2;432(2):230-43.

PMID:
11241388
45.
46.

Developmental differences in alternative splicing of the NR1 protein in rat cortex and cerebellum.

Prybylowski KL, Wolfe BB.

Brain Res Dev Brain Res. 2000 Oct 28;123(2):143-50.

PMID:
11042343
47.

Effects of post-mortem delay on subunits of ionotropic glutamate receptors in human brain.

Wang Y, TesFaye E, Yasuda RP, Mash DC, Armstrong DM, Wolfe BB.

Brain Res Mol Brain Res. 2000 Sep 15;80(2):123-31.

PMID:
11038245
48.

Increased exon 5 expression alters extrasynaptic NMDA receptors in cerebellar neurons.

Prybylowski K, Rumbaugh G, Wolfe BB, Vicini S.

J Neurochem. 2000 Sep;75(3):1140-6.

49.

Changes in NMDA receptor subunit expression in response to contusive spinal cord injury.

Grossman SD, Wolfe BB, Yasuda RP, Wrathall JR.

J Neurochem. 2000 Jul;75(1):174-84.

50.

Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease.

Dunah AW, Wang Y, Yasuda RP, Kameyama K, Huganir RL, Wolfe BB, Standaert DG.

Mol Pharmacol. 2000 Feb;57(2):342-52.

PMID:
10648644

Supplemental Content

Loading ...
Support Center